| Dr Joseph Domino, MD | |
|
3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160-8500 | |
| (913) 588-6119 | |
| Not Available |
| Full Name | Dr Joseph Domino |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164879201 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 94-08923 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Domino, MD 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160-8500 Ph: () - | Dr Joseph Domino, MD 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160-8500 Ph: (913) 588-6119 |
News Archive
Colorectal cancer is the second leading cause of cancer death in the U.S., expected to cause about 51,000 deaths in 2019. But until now, it was unclear which drugs were most effective for which patients.
Biometrics industry expands and becomes more influential as more consumers are turning to digital technology for online & commerce payments while seeking security comfort: NXT-ID, Inc., Google Inc., LifeLock Inc., Visa Inc., Apple Inc. and Fortinet Inc.
Use of a new drug to detect the beta-amyloid plaques in the brain that are hallmark signs of Alzheimer's disease may help doctors diagnose the disease earlier, according to research that will be presented as part of the Emerging Science program (formerly known as Late-Breaking Science) at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
Accountable care organizations have the potential to improve health outcomes and lower costs, but success requires leadership, clear goals and a strong connection between performance and payments, according to a new report by the Commonwealth Fund.
PharmAthene, Inc. announced today that it has achieved an important program milestone in its recombinant protective antigen (rPA) anthrax vaccine program and demonstrated 36 month stability of its rPA drug product candidate previously produced at Avecia Biologics Laboratories in the United Kingdom. The stability data were prepared utilizing a variety of analytical methods and a well characterized mouse challenge potency assay.
› Verified 2 days ago
Anne F Stanton, ARNP Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Dept. Of Neurosurgery, Mail Stop 3021, Kansas City, KS 66160 Phone: 913-588-6180 Fax: 913-588-7570 | |
Bailey Raine Yekzaman, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 3021, Kansas City, KS 66160 Phone: 913-588-1227 | |
Dr. Jean-luc Kalonda Kabangu, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Dr. Sarah Isobel Woodrow, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6125 Fax: 913-588-7570 | |
Jules M Nazzaro, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-5129 Fax: 913-588-5337 | |
Jeremy Charles Peterson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: University Of Kansas Hospital School Of, Dept. Of Neurosurgery, 3901 Rainbow Blvd., Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 Fax: 913-588-7570 |